Inspire Medical Systems Operating Margin 2017-2024 | INSP
Current and historical operating margin for Inspire Medical Systems (INSP) over the last 10 years. The current operating profit margin for Inspire Medical Systems as of December 31, 2024 is 7.92%.
| Inspire Medical Systems Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-12-31 | $0.80B | $0.04B | 4.48% |
| 2024-09-30 | $0.76B | $0.01B | 1.72% |
| 2024-06-30 | $0.71B | $-0.01B | -1.98% |
| 2024-03-31 | $0.66B | $-0.04B | -5.45% |
| 2023-12-31 | $0.63B | $-0.04B | -6.40% |
| 2023-09-30 | $0.57B | $-0.05B | -8.60% |
| 2023-06-30 | $0.53B | $-0.05B | -10.08% |
| 2023-03-31 | $0.47B | $-0.05B | -10.73% |
| 2022-12-31 | $0.41B | $-0.05B | -11.55% |
| 2022-09-30 | $0.35B | $-0.05B | -14.12% |
| 2022-06-30 | $0.30B | $-0.04B | -14.00% |
| 2022-03-31 | $0.26B | $-0.04B | -15.65% |
| 2021-12-31 | $0.23B | $-0.04B | -17.60% |
| 2021-09-30 | $0.20B | $-0.05B | -22.89% |
| 2021-06-30 | $0.18B | $-0.05B | -26.29% |
| 2021-03-31 | $0.13B | $-0.06B | -41.79% |
| 2020-12-31 | $0.12B | $-0.06B | -48.70% |
| 2020-09-30 | $0.10B | $-0.06B | -60.42% |
| 2020-06-30 | $0.08B | $-0.06B | -70.37% |
| 2020-03-31 | $0.09B | $-0.04B | -48.28% |
| 2019-12-31 | $0.08B | $-0.04B | -42.68% |
| 2019-09-30 | $0.07B | $-0.03B | -43.06% |
| 2019-06-30 | $0.06B | $-0.03B | -42.19% |
| 2019-03-31 | $0.06B | $-0.03B | -43.86% |
| 2018-12-31 | $0.05B | $-0.02B | -41.18% |
| 2018-09-30 | $0.04B | $-0.02B | -45.45% |
| 2018-06-30 | $0.04B | $-0.02B | -50.00% |
| 2018-03-31 | $0.03B | $-0.02B | -51.52% |
| 2017-12-31 | $0.03B | $-0.02B | -57.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.616B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.774B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.630B | 121.74 |
| Tempus AI (TEM) | United States | $10.119B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $1.955B | 12.10 |
| Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
| Schrodinger (SDGR) | United States | $1.732B | 0.00 |
| Phreesia (PHR) | United States | $1.434B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.74 |
| Omnicell (OMCL) | United States | $1.154B | 20.35 |
| 10x Genomics (TXG) | United States | $1.016B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 850.00 |
| Claritev (CTEV) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.03 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |